Relative safety of steroid sparing agents in frequently relapsing, steroid dependent and steroid resistant nephrotic syndrome in pediatric patients

Begum, Sabnam Ara; Tripathi, Santanu Kumar; Nandy, Mousumi; Ghosh, Sanat Kumar; Mukherjee, Shatavisa; Saha, Debajyoti.
Artículo | IMSEAR | ID: sea-204721

Documentos relacionados

  1. Levamisole and ANCA positivity in childhood nephrotic syndrome.
  2. Development and Validation of a Highly Sensitive Liquid Chromatography-Tandem Mass Spectrometry Technique to Determine Levamisole in Plasma and Saliva.
  3. Levamisole in childhood idiopathic nephrotic syndrome: new promises, and advocacy for global access.
  4. Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.
  5. Clinical efficacy of mycophenolate mofetil versus levamisole therapy in frequently relapsing and steroid dependent childhood nephrotic syndrome - A retrospective comparative analysis.
  6. Long-term efficacy and safety of common steroid-sparing agents in idiopathic nephrotic children.
  7. Antineutrophil cytoplasmic antibody in children with nephrotic syndrome treated with levamisole: a cross-sectional cohort study.
  8. Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.
  9. The effect of levamisole on kidney function in children with steroid-sensitive nephrotic syndrome.
  10. Saliva monitoring of prednisolone in children with first onset steroid-sensitive nephrotic syndrome: Is it possible?